Genecentric therapeutics Headquarters & Office Locations

Genecentric therapeutics (Private) is headquartered in Durham, North Carolina, United States. Founded in 2011, the company operates across 1 countries with approximately 36 employees worldwide.

Where is Genecentric therapeutics's main office?

Genecentric therapeutics's main headquarters office is located at 100 Capitola Drive suite 275, Durham, North Carolina 27713. This serves as the company's primary corporate address and is home to its executive leadership team.

Genecentric therapeutics regional offices

Beyond its headquarters in Durham, Genecentric therapeutics maintains 5 offices across 1 countries. Regional offices span 1 countries.

Genecentric therapeutics contact information

The main switchboard for Genecentric therapeutics headquarters can be reached at 19199736544. For investor relations, visit genecentric.com/investor-relations.

What does Genecentric therapeutics do?

GeneCentric Therapeutics engages in developing and commercializing molecular diagnostic tests for oncologists and patients. The company currently has two unique platform technologies including The Lung Subtype Platform (LSP) stratifies lung cancer patients into subtypes, which are important for appropriate therapeutic selection. The first application of LSP was licensed to and independently developed by Laboratory Corporation of America Holdings (“LabCorp”) and is now available through its specialty testing business, Integrated Oncology, as HistoPlusSM: Lung Cancer. Its second platform technology is the Hypoxia Signature which has the potential to identify patients that respond to anti-angiogenesis therapies. GeneCentric utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and, most importantly, patients. The company was incorporated in 2011 and is based in Durham, North Carolina.